Home › Immunoglobulin Light-chain Amyloidosis › Arizona

Pag-aaral pangklinika para sa Immunoglobulin Light-chain Amyloidosis sa Arizona

3 pag-aaral para sa Immunoglobulin Light-chain Amyloidosis ang naghahanap ng mga kalahok sa mga site sa Arizona.

Opisyal na teksto ng pag-aaral (English)

Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial

Mayo Clinic in Arizona, Scottsdale

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05898646

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

Research Site, Phoenix

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT07081646

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

CTCA at Western Regional Medical Center, Goodyear
Banner University Medical Center - Tucson, Tucson
University of Arizona Cancer Center-North Campus, Tucson

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT06022939

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.